To examine the impact of NF-κB inhibition on DNA DSB repair, the ability of NSCLC cells to resolve DSB-induced γ-H2AX foci37 was assessed by immunofluorescence. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.